# UC Denver Diabetes Research Center

> **NIH NIH P30** · UNIVERSITY OF COLORADO DENVER · 2024 · $1,309,921

## Abstract

CENTER OVERVIEW
PROJECT SUMMARY/ABSTRACT
The University of Colorado Denver (UC Denver) is world renowned for basic, translational, and clinical diabetes
research and treatment of both Type 1 and Type 2 diabetes (T1D and T2D), and their related complications. The
proposed University of Colorado Diabetes Research Center (UC Denver DRC) will strengthen diabetes research
in Colorado by providing: 1) state-of-the-art research technologies and specialized resources to maximize
effective and innovative research; 2) access to patient samples and data; 3) enrichment programs, education
and seminar series to the diabetes community; and 4) by attracting new scientists into the diabetes field through
the Pilot and Feasibility program. These objectives will be realized by providing improved infrastructure and
access to specialized reagents and resources, and an environment that promotes scientific interactions, research
discoveries, and progress towards diabetes treatment and cures. The UC Denver DRC will be primarily located
on the rapidly growing Anschutz Medical Campus (AMC) in Aurora, Colorado where the majority of the UC
Denver clinical and research departments are located. This unique multi-hospital and academic campus
configuration allows for a broad diabetes research base, which currently includes 88 basic, translational, and
clinical scientific investigators across 17 departments and divisions at UC AMC who currently bring
diabetes/diabetes-related direct cost grant support totaling > $65 million in individual grants and >$14
million in center and training grants. Drs. Lori Sussel, PhD. and Jane Reusch, MD bring together
complementary areas of scientific backgrounds and expertise to oversee the organization and scientific focus of
the UC Denver DRC. We will implement four Biomedical Research Cores to provide cutting-edge technologies
in Clinical Resources (fully integrated databases for tracking of study participants, bio-samples and data),
Tissue Procurement and Processing (rodent tissue and islet isolation, human islet and tissue procurement,
histology services, cell culture bank), Diabetes Modeling (human stem cell-derived in vitro cell and organoid
models, gene editing), and Cell and Tissue Analysis (advanced microscopy, flow cytometry, specialized
CyTOF and MIBI reagents for the diabetes community). The UC Denver DRC will also establish a Pilot and
Feasibility Program to recruit young faculty into diabetes and diabetes-related research, and encourage
established investigators from other fields to enter the diabetes field. The Dean of the UC Denver School of
Medicine has pledged to supplement the P&F budget by $100,000 each year to promote an increased diabetes
research presence on campus. Finally, the UC Denver DRC Enrichment Program will promote the interaction
between diabetes researchers at UC AMC by providing seminar forums for exchange of research findings,
providing opportunities to form collaborative relationships, and encouraging cross-p...

## Key facts

- **NIH application ID:** 10833181
- **Project number:** 5P30DK116073-05
- **Recipient organization:** UNIVERSITY OF COLORADO DENVER
- **Principal Investigator:** LORI SUSSEL
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $1,309,921
- **Award type:** 5
- **Project period:** 2020-04-01 → 2025-08-18

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10833181

## Citation

> US National Institutes of Health, RePORTER application 10833181, UC Denver Diabetes Research Center (5P30DK116073-05). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10833181. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*